top of page

Intelligent Drug Design

Decentralized AI Infrastructure & Quantum Chemistry for Autonomous Drug Discovery

Qubigen deploys tailorable generative tensor models + first-principles physics-based engines in isolated air-gapped runtimes.

​

Your data.   Your AI.   Your moat.

Qubigen data representation

Tailored novel or optimized molecules from protected project data

Generative models and quantum chemistry runtimes learn from internal project data in a secure edge environment deployed for you.

The Qubigen Platform automatically tailors these AI models for your exclusive use for generating and prioritizing molecular structures based on your needs and objectives.

Decentralized Edge-based Learning

Qubigen’s decentralized edge architecture allows high-performing tensor models to learn directly from distributed and unoptimized internal project data, without centralizing raw IP or exposing sensitive results.

Autonomous Generative Execution

Driven by powerful foundational tensor architectures and automated computational workflows, each Qubigen deployment can generate high-potency, synthetically feasible drug candidates tailored to your target protein structures and ADMET profiles.

Precision SAR & Candidate Optimization

 Qubigen accelerates candidate prioritization and minimizes wasted synthesis cycles by combining generative tensor models with parallelized, first-principles quantum chemistry (QM) runtimes.

Air-Gapped Security 

Sensitive project data never leaves the secure environment of your deployment. Federated learning, quantum mechanics calculations and execution agents operate within isolated, air-gapped runtimes, ensuring client-side data isolation.

Qubigen data representation

Designing better quality candidates means fewer false positives, shortening the drug development timeline and reducing development risk.

Qubigen's unique blend of technologies utilizes extensive scientific data, and is tailorable to specific protein targets and ADMET profiles.

Collaborations & Partnerships

Partner Locations
Partner Institutes
Synthesis250x.png
Viva250x.jpg
UPenn250x.png
Florey1.png
USyd_square.png
AdelaideUniversity250x.png
Flinders.png
Bio21_square.png
SyzOnc250x.png
Melbourne_Uni250x.png
QIMR250x.png
IMC_square.png
ONJ250x.png
govSA250x.png
Harvard250x.png
Broad250x.png
Doherty250x.png
Chordoma-Foundation-Logo_edited.jpg
DZIF_square.png
La_Trobe250x.png
blank

Experience the Future
of Drug Design

AI-driven drug design and lead optimization reduces the time to clinical trial, allowing you to focus on the most promising candidates earlier in the drug development process.

Qubigen data representation

Unleashing Technological Excellence

10+

AI Drug Discovery Projects

50K+

Virtual Screening Simulations

100M+

Quantum Chemistry Computations

22

50+

5

Innovative Solutions

enquiries@qubigen.com​

Bio21 Institute

30 Flemington Road

Parkville VIC 3052

Australia

Your data.   Your AI.   Your moat.

Connect with Us

  • X
  • LinkedIn

© 2025 Qubigen. All rights reserved.

bottom of page